Immunome, Inc. (IMNM)

Immunome Stock Forecast

Stock Price Forecast

The 10 analysts that cover Immunome stock have a consensus rating of "Strong Buy" and an average price target of $32.8, which forecasts a 67.18% increase in the stock price over the next year. The lowest target is $22 and the highest is $40.

Price Target: $32.8 (+67.18%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$22	$32.8	$35	$40
Change	+12.13%	+67.18%	+78.39%	+103.87%

Analyst Ratings

The average analyst rating for Immunome stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	4	4	5	5	6	6
Buy	5	4	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	8	9	9	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Adam Vogel Craig-Hallum	Craig-Hallum	Strong Buy Maintains $33 → $36	Strong Buy	Maintains	$33 → $36	+83.49%	Mar 4, 2026
Sudan Loganathan Stephens & Co.	Stephens & Co.	Buy Maintains $33 → $30	Buy	Maintains	$33 → $30	+52.91%	Mar 4, 2026
Andres Y. Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $40	Strong Buy	Initiates	$40	+103.87%	Feb 12, 2026
David Nierengarten Wedbush	Wedbush	Buy Reiterates $31	Buy	Reiterates	$31	+58.00%	Jan 15, 2026
Chad Messer Lake Street	Lake Street	Strong Buy Maintains $22 → $32	Strong Buy	Maintains	$22 → $32	+63.10%	Dec 16, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

6.54M

Decreased by -5.79%

from 6.94M

Revenue Next Year

80.26M

Increased by 1,127.34%

from 6.54M

EPS This Year

-2.69

from -2.43

EPS Next Year

-2.30

from -2.69

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	14.02M	9.04M	6.94M	6.54M	80.26M
Revenue Growth	-	-	-	-35.50%	-23.23%	-5.79%	1,127.34%
EPS	-2.14	-3.09	-5.38	-5.00	-2.43	-2.69	-2.30
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	27.9M	227.2M
Avg	6.5M	80.3M
Low	n/a	6.9M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	302.4%	3,374.5%
Avg	-5.8%	1,127.3%
Low	-	4.9%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-2.02	-1.60
Avg	-2.69	-2.30
Low	-3.45	-3.49

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.